Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study.

What the trial testedas reported · 379 people · 2011

Not counted

+3.04+1.73 to +4.35

As reported

difference 3.04, 95% CI 1.73–4.35

the abstract, start to end

… was 1.66 [difference between groups 3.04 (95% CI 1.73-4.35), P<0.0001].

… (differences: current treatment 0.37, P=0.0093; convenience 0.68, …

← favours treatmentfavours comparator →

could be chance

No interval given · direction only, strength unknown

Quality of life & behaviour

3.041.73–4.35

Quality of life & behaviour

0.37

GLP-1 receptor agonistsQuality of life & behaviour

1 / 3

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

this paperpooled ittrialcites it